美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

武田製藥

18.59

+0.05000.27%

成交量：25.67萬

成交額：478.60萬

市值：587.29億

市盈率：82.72

高：18.72

開：18.62

低：18.57

收：18.54

52周最高：18.79

52周最低：12.99

股本：31.59億

流通股本：30.57億

量比：1.15

換手率：0.01%

股息：0.64

股息率：3.43%

每股收益(TTM):0.2247

每股收益(LYR):0.2245

淨資產收益率：1.50%

總資產收益率：2.47%

市淨率：1.19

市盈率(LYR):82.81

資料載入中...

總覽公司新聞資訊公告

武田製藥以17億美元收購Iambic 加碼人工智能藥物研發布局

环球市场播报

武田製藥任命劉燕為武田中國總裁

南方财经网

美國CMS公布第三輪Medicare價格談判名單：15款藥物入選，含Part B產品

BUZZ-2028 年醫療保險價格表新增 15 種藥品，美國製藥商業績下滑

武田(TAK.US)1類新藥奧博雷通片擬納入優先審評適用於1型發作性睡病患者

財報前瞻｜武田製藥本季度營收預計小幅增長，機構觀點偏謹慎

武田製藥(TAK.US)1類新藥「奧博雷通片」在中國申報上市

2026全球醫藥投資風向標：康方生物領銜，五大「顛覆性」新藥叩門FDA

JPM2026 | 武田：8條管線蓄勢待發，3款新藥18個月內上市

產業新聞丨武田公布TYK2抑制劑治療銀屑病3期臨牀研究積極結果

產業新聞 | 諾和諾德向FDA遞交CagriSema上市申請；武田下一代小分子療法達兩項3期試驗雙主要終點……

武田製藥公布銀屑病新藥臨牀研究結果每日一次口服方案有望實現皮損清除

中国网财经

「百萬一針」抗癌藥、阿爾茲海默等用藥在列！醫保商保「雙目錄」重磅出爐

信達生物(01801)完成與武田製藥的全球戰略合作及根據一般授權發行691.38萬股

Neurocrine公司抑鬱症新藥II期研究未達主要終點

GPLP犀牛财经

醫藥行業「砍單潮」來襲，研發管線迎大調整

武田製藥公布的新數據顯示Mezagitamab（TAK-079）在原發性免疫球蛋白A腎病（IgA腎病）治療結束18個月後持續穩定腎功能

武田：砍掉4條管線！押注中國創新

三巨頭同日終止6項臨牀項目！

招銀國際：微升信達生物(01801)目標價至110.62港元與武田製藥達成戰略合作

智通财经网

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TAK/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"武田製藥","latestPrice":18.59,"timestamp":1771513216785,"preClose":18.54,"halted":0,"volume":256728,"delay":0,"changeRate":0.0026968716289105022,"floatShares":3057000000,"shares":3159188548,"eps":0.224727,"marketStatus":"交易中","change":0.05,"latestTime":"02-19 10:00:27 EST","open":18.615,"high":18.72,"low":18.565,"amount":4786049.172719999,"amplitude":0.00836,"askPrice":18.59,"askSize":406,"bidPrice":18.57,"bidSize":130,"shortable":3,"etf":0,"ttmEps":0.224727,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":18.54,"dividendRate":0.034695,"preHourTrading":{"tag":"盘前","latestPrice":18.59,"preClose":18.54,"latestTime":"09:13 EST","volume":24528,"amount":458093.56185600004,"timestamp":1771510427752,"change":0.05,"changeRate":0.002697,"amplitude":0.012945},"postHourTrading":{"tag":"盘后","latestPrice":18.6,"preClose":18.54,"latestTime":"19:00 EST","volume":1793,"amount":33389.2404,"timestamp":1771459243161,"change":0.06,"changeRate":0.003236,"amplitude":0.014461},"volumeRatio":1.154256,"impliedVol":0.334,"impliedVolPercentile":0.494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3057000000,"roa":"2.47%","roe":"1.50%","lyrEps":0.224477,"volumeRatio":1.154256,"shares":3159188548,"dividePrice":0.637758,"high":18.72,"amplitude":0.00836,"preClose":18.54,"low":18.565,"week52Low":12.99,"pbRate":"1.19","psRate":"2.04","week52High":18.788,"institutionHeld":0.1079,"latestPrice":18.59,"committee":-0.514925,"eps":0.224727,"divideRate":0.034307,"volume":256728,"delay":0,"ttmEps":0.224727,"open":18.615,"prevYearClose":15.59,"prevWeekClose":18.46,"prevMonthClose":17.23,"prevQuarterClose":15.59,"fiveDayClose":18.28,"twentyDayClose":16.08,"sixtyDayClose":14.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"盤前","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"盤前","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"盤前","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689570000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-02-17","current":82.5001,"percent":0.9472,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":45.205664,"high":247.195474,"avg":39.639688,"sd":43.611265,"marketCap":57143899484.58},"quantilePoints":[{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-17","current":77.730702,"twenty":15.819699,"median":29.842804,"eighty":45.205664,"marketCap":57143899484.58}],"updateTime":1771488319164},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610653473","title":"武田製藥以17億美元收購Iambic 加碼人工智能藥物研發布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653473","media":"环球市场播报","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653473?lang=zh_tw&edition=fundamental","pubTime":"2026-02-09 21:26","pubTimestamp":1770643560,"startTime":"0","endTime":"0","summary":"私人控股企业Iambic于本周一宣布，已与日本武田制药达成价值超17亿美元的多年期合作，双方将借助人工智能技术，助力研发针对癌症和胃肠道疾病的小分子药物。　　根据协议内容，Iambic将获得首付款，同时还可在药物研发及商业化的各里程碑节点获得超17亿美元的相关款项，此外还能享有药品销售的特许权使用费。　　这笔合作是武田制药继去年与Nabla Bio达成聚焦蛋白类药物的同类合作后，在研发全流程布局人工智能技术的又一重要举措。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-09/doc-inhmfuky5165106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161631","TAK","BK4007"],"gpt_icon":0},{"id":"2607061263","title":"武田製藥任命劉燕為武田中國總裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2607061263","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607061263?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 10:56","pubTimestamp":1769741778,"startTime":"0","endTime":"0","summary":"南方财经1月30日电，据“武田中国”微信公众号消息，日前，武田制药宣布任命刘燕为武田中国总裁，全面负责武田中国（包括香港、澳门地区）的整体战略和业务发展。她也同时成为新成立的武田制药国际事业部管理委员会成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303636687966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2606671475","title":"美國CMS公布第三輪Medicare價格談判名單：15款藥物入選，含Part B產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671475","media":"Minhua笔记","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671475?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 21:26","pubTimestamp":1769606804,"startTime":"0","endTime":"0","summary":"1月27日，美国医疗保险与医疗补助服务中心公布第三轮《通胀削减法案》药品价格谈判名单，共15款药物。据CMS称，这批药品在2024年11月至2025年10月期间，在Medicare Part B和Part D的总支出约为270亿美元，期间共有180万患者使用了这15种药品。虽然IRA首轮筛选出的10种药物以及去年价格谈判达成的15种药物均由药房配发并纳入Medicare Part D的报销范围，但最新的15种药物名单中包含一些纳入Medicare Part B报销范围的由医生用药的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128214629953ec296&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128214629953ec296&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU2500361329.USD","MRK","ABBV","JNJ","LLY","LU2637428348.USD","BK4007","TAK","IE00BKVL7J92.USD","LU0154236417.USD","BK4585","LU1894683348.USD","LU1894683264.USD","GILD","LU0738911758.USD","LU0949170772.SGD","LU1003077747.HKD","NVO","UCB","LU0553294199.USD","BK4208","NVS","RHHBY","LU2346227817.USD","LU0661504455.SGD","BK4599","BMY","GSK","LU0545039389.USD","BK4588","BK4532","LU1093756168.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2606718435","title":"BUZZ-2028 年醫療保險價格表新增 15 種藥品，美國製藥商業績下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2606718435","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606718435?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 19:30","pubTimestamp":1769599812,"startTime":"0","endTime":"0","summary":"** 美国官员指定  15 种药物参加 2028 年医疗保险价格谈判，其中包括 GILD 的 Biktarvy、PFE 的 Xeljanz、诺华的 Cosentyx、ABBV 的 Botox 和 LLY 的 Trulicity。** 经纪公司 BMO 指出，Biktarvy 所面临的医疗保险风险有限，且此前已进行了多轮 IRA 谈判，因此其影响‘可控’。** CMS 将于 6 月 1 日前发出 2028 年的初步报价，并于 2026 年 11 月 30 日前公布最终价格水平。** 2025 年，ABBV 股价上涨约 29%，GILD 股价上涨约 33%，MRK 股价上涨约 6%，BMY 股价下跌约 5%，LLY 股价上涨约 39%，PFE 股价下跌约 6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL4S3YT17G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0070302665.USD","SG9999011175.SGD","IE00BSNM7G36.USD","SG9999014906.USD","LU1868836591.USD","IE00BKVL7J92.USD","LU2111349929.HKD","BK4568","IE00BFSS8Q28.SGD","LU0029864427.USD","TAK","IE00BFSS7M15.SGD","IE0005OL40V9.USD","SG9999001176.USD","LU0128525929.USD","LU1894683264.USD","LU0640476718.USD","LU2347655156.SGD","LU1989771016.USD","BK4585","LU1814569148.SGD","LU0320765489.SGD","LU0708994859.HKD","LU1974910355.USD","LU1430594728.SGD","LU2360032135.SGD","BK4559","IE00B3PB1722.GBP","LU0965509283.SGD","LU1037948897.HKD","IE00BKDWB100.SGD","LU0965509101.SGD","IE00BJJMRZ35.SGD","SG9999015978.USD","LU1093756168.USD","LU0256863811.USD","LU1720051108.HKD","LU0456855351.SGD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999015358.SGD","LU0949170772.SGD","LU2896262040.SGD","LU0170899867.USD","LU1929549753.HKD","LU1623119135.USD","LU0203347892.USD","LU0477156953.USD","LU2602419157.SGD","LU1699723380.USD","SG9999014914.USD","LU1732800096.USD","LU2087621335.USD","LU0289739343.SGD","LU0114720955.EUR","LU2211815571.USD","IE00B42XCP33.USD","LU0211331839.USD","SG9999001440.SGD","LU0820561909.HKD","SG9999015945.SGD","LU0238689110.USD","LU2237443549.SGD","LU0109394709.USD","LU0225284248.USD","SG9999013999.USD","LU1066051498.USD","LU0320765992.SGD","IE00BKPKM429.USD","IE00BBT3K403.USD","LU2361044949.HKD","LU1244550221.USD","LU0124676726.USD","LU0234572021.USD","IE0004445239.USD","LU0545039389.USD","LU2468319806.SGD","LU2168564222.USD","LU0353189680.USD","LU0354030511.USD","ABBV","IE00B1BXHZ80.USD","LU1244550494.USD","IE0002141913.USD","LU0098860793.USD","LU0471298694.HKD","BK4592","LU1989772923.USD","LU1941712348.USD","LU1941712264.USD","LU1032466523.USD","LU2456880835.USD","LU2746668461.USD","LU1670710588.SGD","SGXZ57979304.SGD","LU1883839398.USD","IE00BDGV0183.EUR","LU0306806265.USD","LU1571399168.USD","LU1496350502.SGD","LU0432979614.USD","GILD","LU1232071149.USD","BK4516","SG9999015986.USD","LU0158827948.USD","LU0787776722.HKD","LU2133065610.SGD","LU1291159041.SGD","SG9999018857.SGD","LU0237698245.USD","SG9999014542.SGD","BK4581","LU0267386448.USD","LU0861579265.USD","LU1548497426.USD","LU1868836914.USD","IE00BVYPNV92.GBP","LU2237443382.USD","IE00B4JS1V06.HKD","LU1201861249.SGD","LU2271345857.HKD","LU2750360641.GBP","LU2237443622.USD","LU0006306889.USD","LU0265550946.USD","LU0109391861.USD","LU2491050154.USD","LU2023250843.SGD","IE00B1XK9C88.USD","LU0385154629.USD","LU2750360997.AUD","LU2168563687.JPY","LU0795875086.SGD","LU1934455277.USD","LU2265009873.SGD","SG9999001176.SGD","LU2089284900.SGD","LU2089984988.USD","BK4599","LU2129689514.USD","LU1261432733.SGD","LU0058720904.USD","LU0820561818.USD","LU2471134523.USD","LU2462157665.USD","LU0203202063.USD","LU1066051225.USD","LU2108987350.USD","SGXZ99366536.SGD","LU1718418525.SGD","LU0320765059.SGD","SG9999014575.USD","LU1127390331.HKD","LU0868494617.USD","SG9999014559.SGD","IE00BN8TJ469.HKD","IE0004445015.USD","LU0234570918.USD","LU2746668974.SGD","LU1061106388.HKD","IE00BK4W5L77.USD","LU2112291526.USD","LU1280957306.USD","SG9999002224.SGD","IE00BFXG1179.USD","LU0266013472.USD","LU1988902786.USD","IE00BWXC8680.SGD","LU1839511570.USD","LU2023251221.USD","LLY","LU1066053197.SGD","LU0079474960.USD","LU2168564065.EUR","BK4566","LU0511384066.AUD","LU1585245621.USD","LU2552382058.USD","LU0980610538.SGD","LU2357305700.SGD","LU0225283273.USD","LU0471298777.SGD","GB00BDT5M118.USD","SGXZ51526630.SGD","SG9999014898.SGD","LU1670710661.SGD","SG9999003800.SGD","LU1551013342.USD","LU0912757837.SGD","LU1732799900.SGD","LU0738911758.USD","LU2168564495.EUR","IE00BN29S564.USD","IE000M9KFDE8.USD","LU0289961442.SGD","LU0265550359.USD","LU0648001328.SGD","GSK","LU2324357040.USD","LU0321505868.SGD","LU1496350171.SGD","IE0009355771.USD","LU0965508806.USD","LU2264538146.SGD","IE00BJJMRX11.SGD","IE00B7KXQ091.USD","LU0061475181.USD","LU1057294990.SGD","LU1366192091.USD","LU1804176565.USD","SG9999002232.USD","LU0256863902.USD","LU2360106947.USD","LU1868837300.USD","IE00BZ1G4Q59.USD","LU0985320562.USD","LU1116320737.USD","PFE","IE00B19Z3B42.SGD","LU0198837287.USD","LU0306807586.USD","LU0106261372.USD","SG9999018865.SGD","LU1064131342.USD","LU1778281490.HKD","IE00BFTCPJ56.SGD","LU0211327993.USD","LU2168564149.EUR","BK4533","LU1674673691.USD","MRK","LU0795875169.SGD","LU0823434740.USD","LU2471134952.CNY","LU2417539215.USD","LU0823416689.USD","LU1934455863.HKD","LU0130102774.USD","BK4532","LU0130517989.USD","IE00BJLML261.HKD","LU0689626769.HKD","LU0094547139.USD","LU1066051811.HKD","LU0069063385.USD","IE00BJJMRY28.SGD","LU0310800379.SGD","LU2361045086.USD","LU1551013425.SGD","LU0210536198.USD","LU2087625088.SGD","LU2552382132.HKD","IE00BLSP4452.SGD","LU0158827781.USD","SG9999017495.SGD","LU1035773651.USD","LU0683600562.USD","IE00BK4W5M84.HKD","LU2129689431.USD","BK4534","LU1670711040.USD","BK4583","IE00BGHQF631.EUR","LU0672654240.SGD","LU2028103732.USD","LU1267930573.SGD","LU1868837136.USD","LU2129689605.HKD","LU1894683348.USD","LU1023059063.AUD","IE00B775H168.HKD","LU2063271972.USD","LU2125154935.USD","LU2237443465.HKD","LU0472753341.HKD","LU0211328371.USD","LU2106854487.HKD","LU0353189763.USD","LU2491049909.HKD","LU0417517546.SGD","LU0354030438.USD","LU0553294199.USD","LU2242652126.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0466842654.USD","LU0661504455.SGD","LU0310799852.SGD","LU1712237335.SGD","LU1934455194.USD","SG9999015952.SGD","LU1244550577.SGD","LU2237443895.HKD","LU0203201768.USD","LU0225771236.USD","LU1074936037.SGD","LU2089283258.USD","IE0002270589.USD","IE00BVYPNW00.USD","LU1267930490.SGD","LU0689472784.USD","LU0882574139.USD","SGXZ81514606.USD","LU2552382215.SGD","LU0985481810.HKD","LU2242646821.SGD","LU1162221912.USD","SG9999014880.SGD","LU1267930730.SGD","BK4578","BK4007","LU1868836757.USD","IE00B3T34201.USD","LU2236285917.USD","LU0943347566.SGD","LU1069347547.HKD","BK4550","LU0823434583.USD","LU2491050071.SGD","LU0889565916.HKD","LU0323591593.USD","LU1989772840.SGD","LU0208291251.USD","BMY","LU1093756325.SGD","LU1983299246.USD","LU0057025933.USD","LU1035775433.USD","LU1720051017.SGD","LU0122379950.USD","SGXZ31699556.SGD","LU1003077747.HKD","BK4588","LU2471134879.HKD","LU0882574055.USD","LU0708995401.HKD","LU0289739699.SGD","LU1323610961.USD","BK4139","IE00B19Z3581.USD","SG9999015341.SGD","LU0096364046.USD","LU1116320901.HKD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU2023250504.SGD","LU2361044865.SGD","IE00BLSP4239.USD","LU1069344957.HKD","LU1674673428.USD","LU0786609619.USD","LU2237443978.SGD","LU0316494557.USD","LU0321505439.SGD","LU0203345920.USD","LU2125154778.USD","LU1670711123.USD","LU0965509010.AUD","LU1917777945.USD","SG9999014567.USD","LU0097036916.USD","LU2471134796.USD","LU2461242641.AUD"],"gpt_icon":1},{"id":"2605842904","title":"武田(TAK.US)1類新藥奧博雷通片擬納入優先審評 適用於1型發作性睡病患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2605842904","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605842904?lang=zh_tw&edition=fundamental","pubTime":"2026-01-23 14:43","pubTimestamp":1769150602,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国国家药监局药品审评中心官网近日公示显示，武田申报的1类新药奥博雷通片的上市申请拟纳入优先审评，适用于治疗16岁及以上1型发作性睡病患者。发作性睡病I型是一种罕见的慢性中枢神经系统疾病，由于患者的食欲素神经元大量缺失，导致大脑和脑脊液中食欲素神经肽水平低下。2025年7月，武田宣布奥博雷通片的两项针对NT1的3期研究达到所有主要和次要终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"1158037503","title":"財報前瞻｜武田製藥本季度營收預計小幅增長，機構觀點偏謹慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1158037503","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158037503?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 10:22","pubTimestamp":1769048526,"startTime":"0","endTime":"0","summary":"武田制药将于2026年01月29日发布最新季度财报，市场聚焦营收改善与利润恢复节奏，关注核心管线商业化对利润率的影响。市场一致预期本季度武田制药总收入约为1149.65亿美元，同比增长6.05%，预计EBIT为105.89亿美元，同比增长174.79%；公司上个季度财报口径显示对本季度的收入与利润预期以改善为主，但净利润和每股收益的预测未披露，毛利率与净利率的季度预测数据暂无。近期机构对武田制药的观点偏谨慎，看空比例更高。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜武田制药本季度营收预计小幅增长，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK"],"gpt_icon":0},{"id":"2603683739","title":"武田製藥(TAK.US)1類新藥「奧博雷通片」在中國申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683739","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683739?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 15:32","pubTimestamp":1768548757,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，1月16日，中国国家药监局药品审评中心官网最新公示显示，武田制药申报的1类新药奥博雷通片上市申请获得受理。该产品此前已经被CDE纳入突破性治疗品种，针对1型发作性睡病适应症。其针对NT1适应症的两项3期关键性研究已经达到所有主要和次要终点。在刚刚结束的2026年JPM大会上，武田披露该产品预计于2026年下半年获监管机构批准上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393785.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"武田制药(TAK.US)1类新药“奥博雷通片”在中国申报上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2603879662","title":"2026全球醫藥投資風向標：康方生物領銜，五大「顛覆性」新藥叩門FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2603879662","media":"药财社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603879662?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 13:00","pubTimestamp":1768366800,"startTime":"0","endTime":"0","summary":"康方生物研发的双抗Ivonescimab正式向FDA递交上市申请，叩响全球市场大门。此外，礼来、默沙东、武田等企业的潜在重磅药物有望在今年获美国FDA批准上市。2025年第三季度，诺和诺德的司美格鲁肽以254.62亿美元销售额守住王座，但礼来正以惊人的速度逼近。基于此，武田制药正加速监管申报，计划在2025财年内向美国FDA等全球监管机构提交新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131404953cb136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131404953cb136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","LU0348767384.USD","LU0348783233.USD","LU0348735423.USD","LU2476274308.USD","LU0540923850.HKD","09926","LU0348766576.USD","LU1794554557.SGD","IE00B543WZ88.USD","LU0634319403.HKD","LU0417516738.SGD","LU2399975544.HKD","BK1515","LU2476274720.SGD","LU0348784397.USD","BK1161","09939","LU0348827113.USD","BK1574","IE00BPRC5H50.USD","LU1720050803.USD","LU0348825331.USD","LU0561508036.HKD","LU2488822045.USD","LU1961090484.USD","IE00B5MMRT66.SGD","TAK","LU0417516571.SGD","LU0417516902.SGD"],"gpt_icon":0},{"id":"2603929656","title":"JPM2026 | 武田：8條管線蓄勢待發，3款新藥18個月內上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2603929656","media":"医药魔方","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603929656?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 10:24","pubTimestamp":1768357480,"startTime":"0","endTime":"0","summary":"在众多管线资产中，三款核心药物尤为引人注目，将在未来18个月内密集登陆市场，开启武田增长新周期。该药凭借对日间嗜睡、猝倒症等症状的全面改善，有望重塑NT1治疗格局，预计2026年下半年上市。Rusfertide已获得突破性疗法、快速通道和孤儿药三重认定，预计2026年下半年上市。该药预计2027年上半年上市，有望成为一线治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114103933a4c11941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114103933a4c11941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESS","IE00BDCRKT87.USD","LU0868494617.USD","LU1551013342.USD","IE00BKVL7J92.USD","LU1363072403.SGD","LU0170899867.USD","LU2213496289.HKD","LU2357305700.SGD","LU1720051017.SGD","LU0234572021.USD","LU1720051108.HKD","IE00BYXW3230.USD","BK4504","IE00B1BXHZ80.USD","BK4007","IE00BN8TJ469.HKD","LU2023250330.USD","IE00B1XK9C88.USD","LU0345770308.USD","LU2505996681.GBP","LU0070302665.USD","IE00BKDWB100.SGD","LU0251132253.USD","LU1244550494.USD","LU1280957306.USD","LU2756315664.SGD","TAK","LU0496365809.HKD","BK4534","LU2417539215.USD","LU2430703251.USD","LU0265550946.USD","LU0882574139.USD","LU0320765646.SGD","LU0106831901.USD","LU1894683348.USD","SG9999002232.USD","LU2264538146.SGD","LU0211331839.USD","LU1162221912.USD","BK4581","LU0211328371.USD","LU1668664300.SGD","LU2756315318.SGD","LU1244550221.USD","LU2505996509.AUD","LU0265550359.USD","LU0787776722.HKD","LU0203347892.USD"],"gpt_icon":0},{"id":"2593637123","title":"產業新聞丨武田公布TYK2抑制劑治療銀屑病3期臨牀研究積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2593637123","media":"医药观澜","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593637123?lang=zh_tw&edition=fundamental","pubTime":"2025-12-20 12:12","pubTimestamp":1766203940,"startTime":"0","endTime":"0","summary":"武田制药计划在即将举行的医学会议上公布研究数据，并计划自2026财年向美国FDA及其他监管机构递交新药上市申请。Zasocitinib是一款在研的新一代高选择性口服TYK2抑制剂，可在24小时内持续抑制IL-23以及其他驱动疾病进展的核心免疫通路。武田目前正开展Zasocitinib与在斑块状银屑病中的研究，并推进其在银屑病关节炎中的3期临床试验。Zasocitinib目前仍处于研究阶段，尚未获得任何监管机构的上市批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220121640a46276e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220121640a46276e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2592180118","title":"產業新聞 | 諾和諾德向FDA遞交CagriSema上市申請；武田下一代小分子療法達兩項3期試驗雙主要終點……","url":"https://stock-news.laohu8.com/highlight/detail?id=2592180118","media":"药明康德","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592180118?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 07:32","pubTimestamp":1766100744,"startTime":"0","endTime":"0","summary":"诺和诺德向FDA递交CagriSema上市申请诺和诺德今日宣布，已向美国FDA递交CagriSema的新药申请。根据新闻稿，若获批，CagriSema将成为首个可注射GLP-1受体激动剂+胰淀素类似物的联合治疗方案。而在假设所有患者均持续用药的前提下，CagriSema组在第68周的体重下降幅度为22.7%，安慰剂组为2.3%。此外，CagriSema组有91.9%的受试者体重下降幅度达到或超过5%，而安慰剂组为31.5%。两项试验均为随机、多中心、双盲设计，并设置安慰剂及活性药物对照。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219073557a6b454f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219073557a6b454f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","TAK","BK4007","BK4599","LU1093756325.SGD","BK4532","BK4588"],"gpt_icon":1},{"id":"2592909774","title":"武田製藥公布銀屑病新藥臨牀研究結果 每日一次口服方案有望實現皮損清除","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909774","media":"中国网财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909774?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 21:31","pubTimestamp":1766064673,"startTime":"0","endTime":"0","summary":"中国网财经12月18日讯武田制药今日宣布，其针对中重度斑块状银屑病(PsO)成人患者的新一代、高选择性口服酪氨酸激酶2(TYK2)抑制剂Zasocitinib(TAK-279)在两项关键性3期、随机、多中心、双盲、安慰剂与活性对照研究中取得积极的主要结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512183595727826.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595727826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2589879327","title":"「百萬一針」抗癌藥、阿爾茲海默等用藥在列！醫保商保「雙目錄」重磅出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2589879327","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589879327?lang=zh_tw&edition=fundamental","pubTime":"2025-12-07 15:51","pubTimestamp":1765093912,"startTime":"0","endTime":"0","summary":"12月7日上午，2025年国家医保药品目录及首版商保创新药目录在广州发布。2025年国家医保药品目录成功新增114种药品，有50种是一类创新药，总体成功率88%，较2024年的76%明显提高。本次目录调整同时调出了29种临床没有供应或可被其他药物更好替代的药品，其中9种尚有相同治疗主成分的其他剂型在目录内，不减少目录编号。与此同时，19种药品纳入首版商保创新药目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512073584579758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2552382215.SGD","LU2552382132.HKD","600196","LU2063271972.USD","ONC","IE0004445239.USD","LU1551013425.SGD","IE00BKPKM429.USD","LU0820561818.USD","BK1161","IE00BWXC8680.SGD","SGXZ31699556.SGD","LU0868494617.USD","LU0094547139.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","BK1587","BK4585","LU0289739699.SGD","LU0471298694.HKD","LU2106854487.HKD","LU0689472784.USD","LU0672654240.SGD","BK0239","SG9999015945.SGD","LU0882574055.USD","LU1430594728.SGD","LU2089984988.USD","LU1804176565.USD","LU2750360641.GBP","LU2168564222.USD","BK0028","LU1868837136.USD","LU2491050154.USD","LU0471298777.SGD","LU0256863811.USD","LU2471134796.USD","BK4533","LU0353189763.USD","IE0009355771.USD","IE00B1XK9C88.USD","IE00BKDWB100.SGD","LU0385154629.USD","LU0786609619.USD","SG9999014898.SGD","SG9999001176.USD","LU1291159041.SGD","LU1670711123.USD","LU1974910355.USD","LU1623119135.USD","LU2242646821.SGD","LU0316494557.USD","IE00B1BXHZ80.USD","IE00BN29S564.USD","BK4007","LU0354030511.USD","LU2125154935.USD","LU0823416689.USD","IE0005OL40V9.USD","LU2237443382.USD","SG9999014914.USD","SG9999018865.SGD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU1032466523.USD","LU2237443895.HKD","LU0466842654.USD","SG9999015986.USD","IE00BK4W5L77.USD","LU1712237335.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU0266013472.USD","LU2237443978.SGD","LU1280957306.USD","LU0106261372.USD","LU1585245621.USD","LU1917777945.USD","IE0004445015.USD","LU1127390331.HKD","LU2357305700.SGD","LU0114720955.EUR","LU0306807586.USD","LU0882574139.USD","LU1720051108.HKD","BK0187","LU0320765059.SGD","LU2471134879.HKD","LU2360032135.SGD","LU2461242641.AUD","LU1074936037.SGD","LU2361044865.SGD","SG9999014906.USD","IE00BJJMRX11.SGD","LU2456880835.USD","06160","SG9999013999.USD","BK0175","LU0109391861.USD","LU1988902786.USD","BK4532","LU1868837300.USD","LU2361044949.HKD","BK0096","LU0417517546.SGD","LU2491050071.SGD","LU0256863902.USD","LU1069344957.HKD","02171","SGXZ99366536.SGD","BK1574","LU0820561909.HKD","LU0061475181.USD","LU1718418525.SGD","LU1670711040.USD","LU1035775433.USD","SG9999017495.SGD","BK4599","LU2417539215.USD","LU2264538146.SGD","LU1323610961.USD","IE00BFXG1179.USD","LU0353189680.USD","LU2108987350.USD","LU1267930730.SGD","LU2168564065.EUR","LU2360106947.USD","LU0321505439.SGD","SG9999014880.SGD","LU2471134523.USD","SGXZ81514606.USD","IE00BJLML261.HKD","02126","IE00B775H168.HKD","LU0889565916.HKD","LU2265009873.SGD","IE00BJJMRY28.SGD","BK4581","LU1814569148.SGD","LU2491049909.HKD","LU2746668974.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU1548497426.USD","IE00B4JS1V06.HKD","BK0183","IE00BSNM7G36.USD","688235","IE0002141913.USD","GB00BDT5M118.USD","LU1023059063.AUD","LU0203201768.USD","LU2125154778.USD","LU2471134952.CNY","LU1670710661.SGD","LU2168564149.EUR","LU2361045086.USD","LU0306806265.USD","LU0225771236.USD","LU2750360997.AUD","LU1093756168.USD","LU1868836914.USD","LU1670710588.SGD","BK0012","LU2242652126.USD","LU2746668461.USD","BK4559","LU0238689110.USD","BK1583","LU0943347566.SGD","IE00BK4W5M84.HKD","LU2211815571.USD","LU0267386448.USD","LU2236285917.USD","SGXZ57979304.SGD","LU0432979614.USD","LU1232071149.USD","BK0196","LU0225284248.USD","BMY","LU1720051017.SGD","SG9999018857.SGD","LU1261432733.SGD","LU1093756325.SGD","LU0823434740.USD","LU0640476718.USD","LU0985481810.HKD","LU1571399168.USD","BK4534","IE00B4R5TH58.HKD","LU2168564495.EUR","LU2133065610.SGD","LU1989771016.USD","LU0237698245.USD","LU0354030438.USD","LU0097036916.USD","IE00BFSS7M15.SGD","LU2237443622.USD","SG9999001176.SGD","BK1585","01228","LU2023250504.SGD","LU2602419157.SGD","LU2237443465.HKD","LU0096364046.USD","LU0006306889.USD","LU0109394709.USD","SG9999015952.SGD","LU1061106388.HKD","LU1868836757.USD","LU2552382058.USD","02196","SGXZ51526630.SGD","LU0323591593.USD","BK0188","IE00BFTCPJ56.SGD","BK0060","LU0321505868.SGD","LU2087625088.SGD","IE00B7KXQ091.USD","LU0058720904.USD","LU0708995401.HKD","LU1366192091.USD","LU0079474960.USD","LU0122379950.USD","LU2168563687.JPY","LU1868836591.USD","LU0456855351.SGD","LU2112291526.USD","LU0198837287.USD","LU1983299246.USD","LU2237443549.SGD","BK4588","BK4516","LU2324357040.USD","TAK","LU0234572021.USD","LU0203202063.USD","LU2237438978.USD","LU0823434583.USD","LU0320765992.SGD","LU1551013342.USD"],"gpt_icon":1},{"id":"2589685310","title":"信達生物(01801)完成與武田製藥的全球戰略合作及根據一般授權發行691.38萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589685310","media":"智通财经","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589685310?lang=zh_tw&edition=fundamental","pubTime":"2025-12-05 07:15","pubTimestamp":1764890112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信达生物 发布公告，内容有关信达生物与武田制药达成全球战略合作，许可、选择权及合作协议及股份发行协议各自的所有先决条件均已达成或获豁免(如适用)。于股份发行协议完成后，公司向认购人配发及发行691.38万股股份，占发行认购股份后公司已发行股本的约0.40%。配发及发行认购股份的所得款项总额约为7.78亿港元，而所得款项净额约为7.77亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0455707207.USD","BK1589","BK1583","HK0000165453.HKD","LU1969619763.USD","LU2097828474.EUR","LU2097828805.USD","LU2488822045.USD","01801","LU2328871848.SGD","TAK","BK1161","LU2097828714.EUR","LU2097828631.EUR","LU2242644610.SGD","BK4007","LU0502904849.HKD","LU2097828557.USD"],"gpt_icon":0},{"id":"2584786920","title":"Neurocrine公司抑鬱症新藥II期研究未達主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2584786920","media":"GPLP犀牛财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584786920?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 19:34","pubTimestamp":1763552095,"startTime":"0","endTime":"0","summary":"近日，神经科学领域的生物制药公司Neurocrine Biosciences宣布，在研抑郁症药物NBI-1070770的II期临床试验未能达到预设主要终点，这一结果也为其与武田制药的合作研发项目再添波折。该药物的研发权益源于2020年Neurocrine与武田的合作，当时武田授予其七个在研药物的独家许可，NBI-1070770便是其中针对抑郁症的核心资产之一。Neurocrine在声明中指出，NBI-1070770整体耐受性良好，试验期间未报告严重不良事件，但所有剂量组均未在主要终点上展现出优于安慰剂的统计学差异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119193517950e580f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119193517950e580f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2581285230","title":"醫藥行業 「砍單潮」 來襲，研發管線迎大調整","url":"https://stock-news.laohu8.com/highlight/detail?id=2581285230","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581285230?lang=zh_tw&edition=fundamental","pubTime":"2025-11-08 16:27","pubTimestamp":1762590458,"startTime":"0","endTime":"0","summary":"11月医药行业 “砍单潮” 打破了研发领域的平静。此次终止的项目中，“数据未达预期” 成为高频原因，暴露出前沿疗法的研发痛点。阿斯利康的 MASH 药物 AZD2693 则在 2b 期试验中因 “疗效不佳” 被叫停，成为该领域研发折戟的又一案例。阿斯利康的调整同样遵循 “优先级法则”，终止 KRAS G12D 抑制剂 AZD0022 等项目，正是为了聚焦自主研发的下一代 ADC 等核心管线。辉瑞仍保有 101 个在研项目，阿斯利康在 ADC 领域的自主研发持续加码。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108162941a6eaa43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108162941a6eaa43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","LU0154236417.USD","BK4585","IE00BKVL7J92.USD","LU0225284248.USD","LU0225771236.USD","LU0289739699.SGD","IE00BLSP4452.SGD","LU0868494617.USD","LU1894683264.USD","TAK","SGXZ57979304.SGD","LU1093756168.USD","LU1093756325.SGD","BK4599","SG9999011175.SGD","LU0306806265.USD","LU0170899867.USD","LU1894683348.USD","BK4532","BK4534","NVO","SG9999001176.USD","LU0321505868.SGD","SG9999013999.USD","IE00B19Z3581.USD","LU1023059063.AUD","BK4568","PFE","LU1057294990.SGD","LU1883839398.USD","IE000M9KFDE8.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","BK4588","LU1066051498.USD","SG9999001176.SGD","LU0985481810.HKD","SG9999002232.USD","BK4007","IE0002270589.USD","LU0321505439.SGD","LU0456855351.SGD","IE00BBT3K403.USD","BK4581","BK4550","LU0234572021.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4592","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2582989865","title":"武田製藥公布的新數據顯示Mezagitamab（TAK-079）在原發性免疫球蛋白A腎病（IgA腎病）治療結束18個月後持續穩定腎功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2582989865","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582989865?lang=zh_tw&edition=fundamental","pubTime":"2025-11-08 15:14","pubTimestamp":1762586040,"startTime":"0","endTime":"0","summary":"在本研究中，Mezagitamab总体耐受性良好，未发现新的安全性问题。2025年10月，欧洲药品管理局授予 Mezagitamab孤儿药资格认定，用于治疗原发性IgA肾病。2025年8月，美国食品药品监督管理局授予 Mezagitamab突破性疗法认定，用于治疗对既往治疗反应不足的慢性免疫性血小板减少症成人患者。武田正在评估Mezagitamab的其他适应症。Mezagitamab是一款在研药物，尚未获得任何监管机构的批准使用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4819541_ZH19541_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2580445300","title":"武田：砍掉4條管線！押注中國創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2580445300","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580445300?lang=zh_tw&edition=fundamental","pubTime":"2025-11-01 08:02","pubTimestamp":1761955342,"startTime":"0","endTime":"0","summary":"为扭转局面，武田一方面大刀阔斧地削减早期研发管线，精简布局；另一方面则战略性押注中国创新，本月与信达生物的一笔首付高达12亿美元的重磅交易。这笔交易不仅为武田的肿瘤管线注入了强劲动力，也印证了其对中国创新研发实力的高度认可。然而，武田与中国药企的合作并非首次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101082931a6d99fc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251101082931a6d99fc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0502904849.HKD","BK1589","LU2097828474.EUR","LU1969619763.USD","LU2488822045.USD","BK1161","01801","LU2097828557.USD","LU2242644610.SGD","LU0455707207.USD","LU2097828714.EUR","TAK","00013","LU2097828631.EUR","LU2097828805.USD","BK1583","LU2328871848.SGD"],"gpt_icon":0},{"id":"2580746447","title":"三巨頭同日終止6項臨牀項目！","url":"https://stock-news.laohu8.com/highlight/detail?id=2580746447","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580746447?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 21:01","pubTimestamp":1761915689,"startTime":"0","endTime":"0","summary":"百时美施贵宝 、 礼来 、武田三大跨国药企同步宣布终止6项临床阶段项目，覆盖肿瘤、慢性疼痛、神经疾病等热门治疗领域。BMS此次调整涉及两项关键战略资产，均与此前大额投资布局相关。不过礼来强调与旭化成的licensing 协议仍有效，目前正评估该药物用于其他适应症的可能性。值得注意的是，P2X7靶点此前已多次折戟，GSK、 阿斯利康 等企业均曾因数据或疗效问题终止相关项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031211741a4801ac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031211741a4801ac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2211815571.USD","MSA","BK4007","LU1923622291.USD","BK4143","LU0053671581.USD","BMS","LU0757428866.USD","LU1815336091.USD","TAK","LU0728928796.USD","LU2125909916.SGD","LU2125909759.SGD"],"gpt_icon":0},{"id":"2577932375","title":"招銀國際：微升信達生物(01801)目標價至110.62港元 與武田製藥達成戰略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2577932375","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577932375?lang=zh_tw&edition=fundamental","pubTime":"2025-10-24 15:49","pubTimestamp":1761292155,"startTime":"0","endTime":"0","summary":"截至2025年6月，信达生物资金状况稳健，现金余额为21亿美元，为其全球野心提供稳固财务基础。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251024/20251024154953_76475.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251024/20251024154953_76475.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359301.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01801","TAK"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}